Furthermore, the proposal of NUMB as a possible therapeutic target for Alzheimer’s disease has been taken even further, with the possibility that the therapeutic value of the isoforms could be differentiated. Here, NUMB is linked to early-onset autosomal dominant Alzheimer disease.